ALERE TECHNOLOGIES LIMITED
Get an alert when ALERE TECHNOLOGIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
-£28m
-4.6% lowest in 3 filed years
Employees
—
Average over period
Profit before tax
-£1.2m
+12.7% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | -£16,490 | -£17,084 | -£18,227 | -6.7% | |
| Profit before tax | -£1,196,662 | -£1,374,987 | -£1,200,809 | +12.7% | |
| Net profit | -£1,196,662 | -£1,374,987 | -£1,200,809 | +12.7% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | -£26,345,477 | -£27,546,286 | -4.6% | |
| Net assets | -£24,970,490 | -£26,345,477 | -£27,546,286 | -4.6% | |
| Equity | — | — | — | — | |
| Average employees | 0 | 0 | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £0 | £0 | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Gearing (liabilities / total assets) | 15884.5% | 18821.8% | 21700.0% | |
| Current ratio | 0.01x | 0.01x | 0.00x | |
| Interest cover | -0.01x | -0.01x | -0.02x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 4 times since incorporation
- ALERE TECHNOLOGIES LIMITED 2010-03-26 → present
- STIRLING MEDICAL INNOVATIONS LIMITED 2005-02-25 → 2010-03-26
- CARDIOSURE LIMITED 2005-02-24 → 2005-02-25
- CARDIOSENSE LTD. 2005-01-31 → 2005-02-24
- QUILLCO 185 LIMITED 2004-12-06 → 2005-01-31
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The company's ultimate parent company, Abbott Laboratories, has provided the director of the company with a letter of support stating that they will assist the company in meeting its liabilities as and when they fall due for a period of 12 months from the date of approval of the financial statements for the year ended 31 December 2025. The director has no reason to believe that a material uncertainty exists that may cast significant doubt on the ability of Abbott Laboratories to honour the letter of ongoing financial support. Accordingly, the company continues to adopt the going concern basis in preparing the financial statements.”
Significant events
- “There have been no significant events impacting the company since the year end.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
1 active · 20 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BOND, David Andrew | Director | 2024-06-10 | Sep 1971 | British |
Show 20 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| COULING, Geoffrey | Secretary | 2008-06-10 | 2017-10-03 |
| HANNAH, Thomas Douglas | Secretary | 2005-04-06 | 2008-06-10 |
| POLKA, Hazel Nadyezhda | Secretary | 2005-02-24 | 2005-04-06 |
| QUILL SERVE LIMITED | Corporate Nominee Secretary | 2004-12-06 | 2005-02-24 |
| BAIRD, Graeme | Director | 2011-07-19 | 2013-04-15 |
| BARRY, Douglas John | Director | 2015-09-29 | 2017-10-03 |
| DENNISON, Manus | Director | 2010-08-09 | 2014-06-13 |
| FALLON, Kevin | Director | 2011-08-19 | 2015-02-20 |
| FELLOWS, Trevor | Director | 2017-10-03 | 2024-06-10 |
| HANNAH, Douglas | Director | 2015-02-20 | 2015-12-31 |
| HUTCHISON, Robert | Director | 2005-04-06 | 2008-06-09 |
| LANG, David | Director | 2007-09-26 | 2011-07-19 |
| MCALEER, Jerome Francis | Director | 2005-02-24 | 2014-07-14 |
| MCNICOL, Marcia Elizabeth | Director | 2014-06-13 | 2015-02-20 |
| SAUNDERS, Callum | Director | 2013-04-15 | 2015-02-20 |
| SCOTT, David, Dr | Director | 2005-02-24 | 2014-07-14 |
| TEITEL, David | Director | 2014-10-03 | 2015-09-29 |
| WILSON, Stewart | Director | 2015-02-20 | 2017-12-01 |
| YOOR, Brian Bernard | Director | 2017-10-03 | 2018-08-01 |
| QUILL FORM LIMITED | Corporate Nominee Director | 2004-12-06 | 2005-02-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Abbott Laboratories | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2017-10-03 | Active |
| Alere Switzerland Gmbh | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 108 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-13 | AA | accounts | Accounts with accounts type full | |
| 2026-02-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-13 | AA | accounts | Accounts with accounts type full | |
| 2025-02-06 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-02-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-01-31 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-01-31 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-07-08 | AA | accounts | Accounts with accounts type full | |
| 2024-06-13 | AP01 | officers | Appoint person director company with name date | |
| 2024-06-13 | TM01 | officers | Termination director company with name termination date | |
| 2024-02-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-03 | AA | accounts | Accounts with accounts type full | |
| 2023-02-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-02 | AA | accounts | Accounts with accounts type full | |
| 2022-01-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-27 | AA | accounts | Accounts with accounts type full | |
| 2021-03-24 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2021-03-23 | AD02 | address | Change sail address company with old address new address | |
| 2021-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-09-23 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.